These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36277729)

  • 21. The effects of
    Cheng Y; Liu Y; Lin L; Li D; Peng L; Zheng K; Tao J; Li M
    Ren Fail; 2024 Dec; 46(1):2295425. PubMed ID: 38178377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.
    Zhao L; Ren H; Zhang R; Wang T; Zou Y; Xu H; Li L; Cooper ME; Liu F
    Int Urol Nephrol; 2021 Jun; 53(6):1161-1170. PubMed ID: 33389518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression.
    Zhang J; Xiao X; Wu Y; Yang J; Zou Y; Zhao Y; Yang Q; Liu F
    Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aspartate aminotransferase to alanine aminotransferase ratio and the risk of diabetic nephropathy progression in patients with type 2 diabetes mellitus: A biopsy-based study.
    Wu Y; Liu F
    J Diabetes Complications; 2022 Aug; 36(8):108235. PubMed ID: 35853763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients.
    Zhao L; Zou Y; Zhang J; Zhang R; Ren H; Li L; Guo R; Zhang J; Liu F
    Int J Med Sci; 2020; 17(14):2113-2124. PubMed ID: 32922172
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of Supersonic Shear Wave Imaging-Derived Renal Parenchyma Stiffness Between Diabetes Mellitus Patients With and Without Diabetic Kidney Disease.
    Shi LQ; Sun JW; Miao HH; Zhou XL
    Ultrasound Med Biol; 2020 Jul; 46(7):1630-1640. PubMed ID: 32404297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and pathological characteristics of DKD patients with early-onset type 2 diabetes.
    Wu L; Zhao YY; Li MR; Chang DY; Zhao MH; Chen M
    J Diabetes Complications; 2023 Aug; 37(8):108520. PubMed ID: 37311359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological features and outcomes of diabetic kidney disease with extracapillary hypercellularity: a Japanese single-center experience.
    Saito A; Komatsuda A; Saito M; Kaga H; Abe F; Sawamura M; Nara M; Sato R; Wakui H; Takahashi N
    Clin Exp Nephrol; 2020 Jun; 24(6):509-517. PubMed ID: 32037471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
    Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
    Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of lactate dehydrogenase with risk of renal outcomes and cardiovascular mortality in individuals with diabetic kidney disease.
    Xiao X; Zhang J; Lang Y; Cai L; Yang Q; Liu K; Ji S; Ju X; Liu F
    Diabetes Res Clin Pract; 2023 Sep; 203():110838. PubMed ID: 37478980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort.
    Hirano T; Satoh N; Kodera R; Hirashima T; Suzuki N; Aoki E; Oshima T; Hosoya M; Fujita M; Hayashi T; Ito Y
    J Diabetes Investig; 2022 Apr; 13(4):657-667. PubMed ID: 34665936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerular crescents are associated with the risk of type 2 diabetic kidney disease progression: a retrospective cohort study.
    Bae S; Yun D; Lee SW; Jhee JH; Lee JP; Chang TI; Oh J; Kwon YJ; Kim SG; Lee H; Kim DK; Joo KW; Moon KC; Chin HJ; Han SS
    BMC Nephrol; 2024 May; 25(1):172. PubMed ID: 38769500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into serum metabolic biomarkers for early detection of incident diabetic kidney disease in Chinese patients with type 2 diabetes by random forest.
    Jiang JJ; Sham TT; Gu XF; Chan CO; Dong NP; Lim WH; Song GF; Li SM; Mok DK; Ge N
    Aging (Albany NY); 2024 Feb; 16(4):3420-3530. PubMed ID: 38349886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Segmental Sclerosis and Extracapillary Hypercellularity Predict Diabetic ESRD.
    Mottl AK; Gasim A; Schober FP; Hu Y; Dunnon AK; Hogan SL; Jennette JC
    J Am Soc Nephrol; 2018 Feb; 29(2):694-703. PubMed ID: 29180393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of patients with type 2 diabetes attending a multidisciplinary diabetes kidney disease clinic.
    Low S; Lim SC; Wang J; Yeoh LY; Liu YL; Lim EK; Shao YL; Chui W; Fun S; Chua CL; Subramaniam T; Sum CF
    J Diabetes; 2018 Jul; 10(7):572-580. PubMed ID: 29154443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study.
    Basu M; Pulai S; Neogi S; Banerjee M; Bhattacharyya NP; Sengupta S; Mukhopadhyay P; Ray Chaudhury A; Ghosh S
    BMJ Open Diabetes Res Care; 2022 Dec; 10(6):. PubMed ID: 36517108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease.
    Li H; Shen Y; Yu Z; Huang Y; He T; Xiao T; Li Y; Xiong J; Zhao J
    Front Endocrinol (Lausanne); 2021; 12():731187. PubMed ID: 35095752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-Onset Type 2 Diabetes as a Risk Factor for End-Stage Renal Disease in Patients With Diabetic Kidney Disease.
    Zheng L; Chen X; Luo T; Ran X; Hu J; Cheng Q; Yang S; Wu J; Li Q; Wang Z
    Prev Chronic Dis; 2020 Jul; 17():E50. PubMed ID: 32614772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach.
    Carlsson AC; Nowak C; Lind L; Östgren CJ; Nyström FH; Sundström J; Carrero JJ; Riserus U; Ingelsson E; Fall T; Ärnlöv J
    Ups J Med Sci; 2020 Feb; 125(1):37-43. PubMed ID: 31805809
    [No Abstract]   [Full Text] [Related]  

  • 40. Markers of and risk factors for the development and progression of diabetic kidney disease.
    Macisaac RJ; Ekinci EI; Jerums G
    Am J Kidney Dis; 2014 Feb; 63(2 Suppl 2):S39-62. PubMed ID: 24461729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.